PharmaNetics, Aventis submit Enox 510k

PHAR and partner Aventis (AVE) submitted a 510k with the FDA for PHAR's Rapidpoint Enox test to analyze therapeutic levels of AVE's Lovenox enoxaparin. Lovenox is a low molecular weight heparin to pre...